Any aberration in the signaling of estrogen receptors leads to various types of endocrine disorders and associated cancers, for example, breast cancer, endometrial cancer, and osteoporosis, where the estrogen receptor is a designated clinical target [2]. This evidence concerns the gene ESR1 and breast carcinoma.